nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefenamic acid—AKR1C3—Doxorubicin—ovarian cancer	0.407	0.801	CbGbCtD
Mefenamic acid—CYP2C8—Paclitaxel—ovarian cancer	0.0597	0.117	CbGbCtD
Mefenamic acid—CYP2C9—Paclitaxel—ovarian cancer	0.0416	0.0819	CbGbCtD
Mefenamic acid—PTGS2—ovarian follicle—ovarian cancer	0.0119	0.133	CbGeAlD
Mefenamic acid—AKR1C2—testis—ovarian cancer	0.00748	0.0836	CbGeAlD
Mefenamic acid—PTGS1—oviduct—ovarian cancer	0.00548	0.0613	CbGeAlD
Mefenamic acid—AKR1C2—lymph node—ovarian cancer	0.00542	0.0606	CbGeAlD
Mefenamic acid—AKR1C3—myometrium—ovarian cancer	0.00496	0.0555	CbGeAlD
Mefenamic acid—AKR1C3—Vincristine—Vinorelbine—ovarian cancer	0.00475	0.554	CbGdCrCtD
Mefenamic acid—AKR1C3—uterine cervix—ovarian cancer	0.00386	0.0432	CbGeAlD
Mefenamic acid—AKR1C3—Vinblastine—Vinorelbine—ovarian cancer	0.00382	0.446	CbGdCrCtD
Mefenamic acid—AKR1C3—decidua—ovarian cancer	0.00368	0.0411	CbGeAlD
Mefenamic acid—AKR1C3—endometrium—ovarian cancer	0.00349	0.039	CbGeAlD
Mefenamic acid—AKR1C3—uterus—ovarian cancer	0.00322	0.036	CbGeAlD
Mefenamic acid—AKR1C3—bone marrow—ovarian cancer	0.00273	0.0305	CbGeAlD
Mefenamic acid—AKR1C3—female gonad—ovarian cancer	0.00263	0.0294	CbGeAlD
Mefenamic acid—AKR1C3—vagina—ovarian cancer	0.00262	0.0292	CbGeAlD
Mefenamic acid—Acetylsalicylic acid—TP53—ovarian cancer	0.00259	0.424	CrCbGaD
Mefenamic acid—AKR1C3—testis—ovarian cancer	0.00233	0.0261	CbGeAlD
Mefenamic acid—AKR1C3—lymph node—ovarian cancer	0.00169	0.0189	CbGeAlD
Mefenamic acid—PTGS2—myometrium—ovarian cancer	0.00168	0.0188	CbGeAlD
Mefenamic acid—PTGS2—embryo—ovarian cancer	0.00161	0.018	CbGeAlD
Mefenamic acid—CYP2C8—endometrium—ovarian cancer	0.00152	0.017	CbGeAlD
Mefenamic acid—PTGS1—epithelium—ovarian cancer	0.00138	0.0154	CbGeAlD
Mefenamic acid—PTGS1—uterine cervix—ovarian cancer	0.00137	0.0153	CbGeAlD
Mefenamic acid—PTGS2—epithelium—ovarian cancer	0.00132	0.0147	CbGeAlD
Mefenamic acid—PTGS2—uterine cervix—ovarian cancer	0.00131	0.0146	CbGeAlD
Mefenamic acid—Diclofenac—CXCL8—ovarian cancer	0.00128	0.21	CrCbGaD
Mefenamic acid—CYP2C8—female reproductive system—ovarian cancer	0.00126	0.0141	CbGeAlD
Mefenamic acid—PTGS1—endometrium—ovarian cancer	0.00124	0.0138	CbGeAlD
Mefenamic acid—PTGS2—endometrium—ovarian cancer	0.00118	0.0132	CbGeAlD
Mefenamic acid—CYP2C8—vagina—ovarian cancer	0.00114	0.0128	CbGeAlD
Mefenamic acid—PTGS1—uterus—ovarian cancer	0.00114	0.0127	CbGeAlD
Mefenamic acid—Ketoprofen—CXCL8—ovarian cancer	0.00113	0.186	CrCbGaD
Mefenamic acid—CYP2C9—female reproductive system—ovarian cancer	0.00112	0.0125	CbGeAlD
Mefenamic acid—PTGS2—uterus—ovarian cancer	0.00109	0.0122	CbGeAlD
Mefenamic acid—PTGS1—female reproductive system—ovarian cancer	0.00102	0.0114	CbGeAlD
Mefenamic acid—CYP2C8—testis—ovarian cancer	0.00102	0.0114	CbGeAlD
Mefenamic acid—PTGS2—female reproductive system—ovarian cancer	0.000978	0.0109	CbGeAlD
Mefenamic acid—PTGS1—female gonad—ovarian cancer	0.000931	0.0104	CbGeAlD
Mefenamic acid—PTGS1—vagina—ovarian cancer	0.000925	0.0103	CbGeAlD
Mefenamic acid—PTGS2—bone marrow—ovarian cancer	0.000923	0.0103	CbGeAlD
Mefenamic acid—PTGS2—female gonad—ovarian cancer	0.00089	0.00995	CbGeAlD
Mefenamic acid—PTGS2—vagina—ovarian cancer	0.000884	0.00989	CbGeAlD
Mefenamic acid—PTGS1—testis—ovarian cancer	0.000826	0.00923	CbGeAlD
Mefenamic acid—PTGS1—lymph node—ovarian cancer	0.000599	0.00669	CbGeAlD
Mefenamic acid—PTGS2—lymph node—ovarian cancer	0.000572	0.0064	CbGeAlD
Mefenamic acid—Acetylsalicylic acid—ABCB1—ovarian cancer	0.00043	0.0705	CrCbGaD
Mefenamic acid—Dermatitis—Melphalan—ovarian cancer	0.000355	0.00121	CcSEcCtD
Mefenamic acid—Salicylic acid—ABCB1—ovarian cancer	0.000354	0.0581	CrCbGaD
Mefenamic acid—Asthenia—Vinorelbine—ovarian cancer	0.000353	0.0012	CcSEcCtD
Mefenamic acid—Arrhythmia—Docetaxel—ovarian cancer	0.000353	0.0012	CcSEcCtD
Mefenamic acid—Convulsion—Paclitaxel—ovarian cancer	0.000351	0.0012	CcSEcCtD
Mefenamic acid—Hypertension—Paclitaxel—ovarian cancer	0.00035	0.00119	CcSEcCtD
Mefenamic acid—Alopecia—Docetaxel—ovarian cancer	0.000349	0.00119	CcSEcCtD
Mefenamic acid—Pruritus—Vinorelbine—ovarian cancer	0.000348	0.00118	CcSEcCtD
Mefenamic acid—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.000347	0.00118	CcSEcCtD
Mefenamic acid—Mental disorder—Docetaxel—ovarian cancer	0.000346	0.00118	CcSEcCtD
Mefenamic acid—Anxiety—Paclitaxel—ovarian cancer	0.000344	0.00117	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000343	0.00117	CcSEcCtD
Mefenamic acid—Nausea—Topotecan—ovarian cancer	0.000342	0.00116	CcSEcCtD
Mefenamic acid—Discomfort—Paclitaxel—ovarian cancer	0.000341	0.00116	CcSEcCtD
Mefenamic acid—Gastritis—Epirubicin—ovarian cancer	0.000341	0.00116	CcSEcCtD
Mefenamic acid—Dry mouth—Paclitaxel—ovarian cancer	0.000338	0.00115	CcSEcCtD
Mefenamic acid—Diarrhoea—Vinorelbine—ovarian cancer	0.000337	0.00115	CcSEcCtD
Mefenamic acid—Nausea—Melphalan—ovarian cancer	0.000335	0.00114	CcSEcCtD
Mefenamic acid—Confusional state—Paclitaxel—ovarian cancer	0.000334	0.00114	CcSEcCtD
Mefenamic acid—Asthma—Epirubicin—ovarian cancer	0.000333	0.00113	CcSEcCtD
Mefenamic acid—Oedema—Paclitaxel—ovarian cancer	0.000331	0.00113	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000331	0.00113	CcSEcCtD
Mefenamic acid—Eosinophilia—Epirubicin—ovarian cancer	0.00033	0.00112	CcSEcCtD
Mefenamic acid—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000329	0.00112	CcSEcCtD
Mefenamic acid—Infection—Paclitaxel—ovarian cancer	0.000329	0.00112	CcSEcCtD
Mefenamic acid—Pancreatitis—Epirubicin—ovarian cancer	0.000326	0.00111	CcSEcCtD
Mefenamic acid—Shock—Paclitaxel—ovarian cancer	0.000326	0.00111	CcSEcCtD
Mefenamic acid—Dizziness—Vinorelbine—ovarian cancer	0.000326	0.00111	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000324	0.0011	CcSEcCtD
Mefenamic acid—Tachycardia—Paclitaxel—ovarian cancer	0.000323	0.0011	CcSEcCtD
Mefenamic acid—Skin disorder—Paclitaxel—ovarian cancer	0.000322	0.00109	CcSEcCtD
Mefenamic acid—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000321	0.00109	CcSEcCtD
Mefenamic acid—Anaemia—Docetaxel—ovarian cancer	0.000318	0.00108	CcSEcCtD
Mefenamic acid—Diclofenac—ABCB1—ovarian cancer	0.000317	0.052	CrCbGaD
Mefenamic acid—Pancytopenia—Epirubicin—ovarian cancer	0.000316	0.00108	CcSEcCtD
Mefenamic acid—Anorexia—Paclitaxel—ovarian cancer	0.000316	0.00107	CcSEcCtD
Mefenamic acid—Gastritis—Doxorubicin—ovarian cancer	0.000315	0.00107	CcSEcCtD
Mefenamic acid—Vomiting—Vinorelbine—ovarian cancer	0.000313	0.00106	CcSEcCtD
Mefenamic acid—Dysuria—Epirubicin—ovarian cancer	0.000311	0.00106	CcSEcCtD
Mefenamic acid—Rash—Vinorelbine—ovarian cancer	0.00031	0.00106	CcSEcCtD
Mefenamic acid—Dermatitis—Vinorelbine—ovarian cancer	0.00031	0.00105	CcSEcCtD
Mefenamic acid—Hypotension—Paclitaxel—ovarian cancer	0.000309	0.00105	CcSEcCtD
Mefenamic acid—Headache—Vinorelbine—ovarian cancer	0.000308	0.00105	CcSEcCtD
Mefenamic acid—Syncope—Docetaxel—ovarian cancer	0.000308	0.00105	CcSEcCtD
Mefenamic acid—Asthma—Doxorubicin—ovarian cancer	0.000308	0.00105	CcSEcCtD
Mefenamic acid—Leukopenia—Docetaxel—ovarian cancer	0.000308	0.00105	CcSEcCtD
Mefenamic acid—Eosinophilia—Doxorubicin—ovarian cancer	0.000305	0.00104	CcSEcCtD
Mefenamic acid—Palpitations—Docetaxel—ovarian cancer	0.000304	0.00103	CcSEcCtD
Mefenamic acid—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000304	0.00103	CcSEcCtD
Mefenamic acid—Loss of consciousness—Docetaxel—ovarian cancer	0.000302	0.00103	CcSEcCtD
Mefenamic acid—Pancreatitis—Doxorubicin—ovarian cancer	0.000302	0.00103	CcSEcCtD
Mefenamic acid—Hyperglycaemia—Epirubicin—ovarian cancer	0.0003	0.00102	CcSEcCtD
Mefenamic acid—Insomnia—Paclitaxel—ovarian cancer	0.000299	0.00102	CcSEcCtD
Mefenamic acid—Pneumonia—Epirubicin—ovarian cancer	0.000299	0.00102	CcSEcCtD
Mefenamic acid—Convulsion—Docetaxel—ovarian cancer	0.000298	0.00101	CcSEcCtD
Mefenamic acid—Paraesthesia—Paclitaxel—ovarian cancer	0.000297	0.00101	CcSEcCtD
Mefenamic acid—Hypertension—Docetaxel—ovarian cancer	0.000297	0.00101	CcSEcCtD
Mefenamic acid—Drowsiness—Epirubicin—ovarian cancer	0.000297	0.00101	CcSEcCtD
Mefenamic acid—Dyspnoea—Paclitaxel—ovarian cancer	0.000295	0.001	CcSEcCtD
Mefenamic acid—Somnolence—Paclitaxel—ovarian cancer	0.000294	0.001	CcSEcCtD
Mefenamic acid—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000294	0.001	CcSEcCtD
Mefenamic acid—Pancytopenia—Doxorubicin—ovarian cancer	0.000292	0.000995	CcSEcCtD
Mefenamic acid—Nausea—Vinorelbine—ovarian cancer	0.000292	0.000995	CcSEcCtD
Mefenamic acid—Renal failure—Epirubicin—ovarian cancer	0.000292	0.000993	CcSEcCtD
Mefenamic acid—Dyspepsia—Paclitaxel—ovarian cancer	0.000291	0.000992	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000291	0.000989	CcSEcCtD
Mefenamic acid—Stomatitis—Epirubicin—ovarian cancer	0.000289	0.000984	CcSEcCtD
Mefenamic acid—Jaundice—Epirubicin—ovarian cancer	0.000289	0.000984	CcSEcCtD
Mefenamic acid—Conjunctivitis—Epirubicin—ovarian cancer	0.000288	0.000982	CcSEcCtD
Mefenamic acid—Dysuria—Doxorubicin—ovarian cancer	0.000288	0.00098	CcSEcCtD
Mefenamic acid—Decreased appetite—Paclitaxel—ovarian cancer	0.000288	0.000979	CcSEcCtD
Mefenamic acid—Dry mouth—Docetaxel—ovarian cancer	0.000286	0.000974	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000286	0.000973	CcSEcCtD
Mefenamic acid—Constipation—Paclitaxel—ovarian cancer	0.000283	0.000963	CcSEcCtD
Mefenamic acid—Haematuria—Epirubicin—ovarian cancer	0.000283	0.000963	CcSEcCtD
Mefenamic acid—Confusional state—Docetaxel—ovarian cancer	0.000283	0.000963	CcSEcCtD
Mefenamic acid—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000281	0.000956	CcSEcCtD
Mefenamic acid—Oedema—Docetaxel—ovarian cancer	0.000281	0.000955	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Docetaxel—ovarian cancer	0.000281	0.000955	CcSEcCtD
Mefenamic acid—Infection—Docetaxel—ovarian cancer	0.000279	0.000949	CcSEcCtD
Mefenamic acid—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000278	0.000945	CcSEcCtD
Mefenamic acid—Agranulocytosis—Epirubicin—ovarian cancer	0.000277	0.000942	CcSEcCtD
Mefenamic acid—Pneumonia—Doxorubicin—ovarian cancer	0.000276	0.00094	CcSEcCtD
Mefenamic acid—Shock—Docetaxel—ovarian cancer	0.000276	0.000939	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Docetaxel—ovarian cancer	0.000275	0.000935	CcSEcCtD
Mefenamic acid—Drowsiness—Doxorubicin—ovarian cancer	0.000275	0.000934	CcSEcCtD
Mefenamic acid—Tachycardia—Docetaxel—ovarian cancer	0.000274	0.000932	CcSEcCtD
Mefenamic acid—Feeling abnormal—Paclitaxel—ovarian cancer	0.000273	0.000928	CcSEcCtD
Mefenamic acid—Skin disorder—Docetaxel—ovarian cancer	0.000273	0.000927	CcSEcCtD
Mefenamic acid—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000272	0.000926	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000271	0.000921	CcSEcCtD
Mefenamic acid—Renal failure—Doxorubicin—ovarian cancer	0.00027	0.000918	CcSEcCtD
Mefenamic acid—Haemoglobin—Epirubicin—ovarian cancer	0.000268	0.000911	CcSEcCtD
Mefenamic acid—Jaundice—Doxorubicin—ovarian cancer	0.000268	0.000911	CcSEcCtD
Mefenamic acid—Stomatitis—Doxorubicin—ovarian cancer	0.000268	0.000911	CcSEcCtD
Mefenamic acid—Anorexia—Docetaxel—ovarian cancer	0.000268	0.00091	CcSEcCtD
Mefenamic acid—Conjunctivitis—Doxorubicin—ovarian cancer	0.000267	0.000908	CcSEcCtD
Mefenamic acid—Hepatitis—Epirubicin—ovarian cancer	0.000266	0.000906	CcSEcCtD
Mefenamic acid—Haemorrhage—Epirubicin—ovarian cancer	0.000266	0.000906	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Epirubicin—ovarian cancer	0.000263	0.000895	CcSEcCtD
Mefenamic acid—Urticaria—Paclitaxel—ovarian cancer	0.000263	0.000895	CcSEcCtD
Mefenamic acid—Hypotension—Docetaxel—ovarian cancer	0.000262	0.000892	CcSEcCtD
Mefenamic acid—Haematuria—Doxorubicin—ovarian cancer	0.000262	0.000891	CcSEcCtD
Mefenamic acid—Abdominal pain—Paclitaxel—ovarian cancer	0.000262	0.00089	CcSEcCtD
Mefenamic acid—Body temperature increased—Paclitaxel—ovarian cancer	0.000262	0.00089	CcSEcCtD
Mefenamic acid—Urethral disorder—Epirubicin—ovarian cancer	0.000261	0.000889	CcSEcCtD
Mefenamic acid—Agranulocytosis—Doxorubicin—ovarian cancer	0.000256	0.000872	CcSEcCtD
Mefenamic acid—Insomnia—Docetaxel—ovarian cancer	0.000254	0.000864	CcSEcCtD
Mefenamic acid—Paraesthesia—Docetaxel—ovarian cancer	0.000252	0.000857	CcSEcCtD
Mefenamic acid—Erythema multiforme—Epirubicin—ovarian cancer	0.000252	0.000857	CcSEcCtD
Mefenamic acid—Dyspnoea—Docetaxel—ovarian cancer	0.00025	0.000851	CcSEcCtD
Mefenamic acid—Somnolence—Docetaxel—ovarian cancer	0.000249	0.000849	CcSEcCtD
Mefenamic acid—Tinnitus—Epirubicin—ovarian cancer	0.000248	0.000845	CcSEcCtD
Mefenamic acid—Haemoglobin—Doxorubicin—ovarian cancer	0.000248	0.000843	CcSEcCtD
Mefenamic acid—Dyspepsia—Docetaxel—ovarian cancer	0.000247	0.00084	CcSEcCtD
Mefenamic acid—Hepatitis—Doxorubicin—ovarian cancer	0.000247	0.000839	CcSEcCtD
Mefenamic acid—Haemorrhage—Doxorubicin—ovarian cancer	0.000247	0.000839	CcSEcCtD
Mefenamic acid—Decreased appetite—Docetaxel—ovarian cancer	0.000244	0.00083	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000243	0.000828	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000242	0.000824	CcSEcCtD
Mefenamic acid—Urethral disorder—Doxorubicin—ovarian cancer	0.000242	0.000822	CcSEcCtD
Mefenamic acid—Constipation—Docetaxel—ovarian cancer	0.00024	0.000816	CcSEcCtD
Mefenamic acid—Arrhythmia—Epirubicin—ovarian cancer	0.000238	0.00081	CcSEcCtD
Mefenamic acid—Asthenia—Paclitaxel—ovarian cancer	0.000238	0.000808	CcSEcCtD
Mefenamic acid—Alopecia—Epirubicin—ovarian cancer	0.000235	0.000801	CcSEcCtD
Mefenamic acid—Pruritus—Paclitaxel—ovarian cancer	0.000234	0.000797	CcSEcCtD
Mefenamic acid—Mental disorder—Epirubicin—ovarian cancer	0.000233	0.000794	CcSEcCtD
Mefenamic acid—Erythema multiforme—Doxorubicin—ovarian cancer	0.000233	0.000793	CcSEcCtD
Mefenamic acid—Feeling abnormal—Docetaxel—ovarian cancer	0.000231	0.000787	CcSEcCtD
Mefenamic acid—Tinnitus—Doxorubicin—ovarian cancer	0.00023	0.000782	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000229	0.000781	CcSEcCtD
Mefenamic acid—Flatulence—Epirubicin—ovarian cancer	0.000229	0.000778	CcSEcCtD
Mefenamic acid—Tension—Epirubicin—ovarian cancer	0.000228	0.000774	CcSEcCtD
Mefenamic acid—Diarrhoea—Paclitaxel—ovarian cancer	0.000227	0.000771	CcSEcCtD
Mefenamic acid—Nervousness—Epirubicin—ovarian cancer	0.000225	0.000766	CcSEcCtD
Mefenamic acid—Abdominal pain—Docetaxel—ovarian cancer	0.000222	0.000755	CcSEcCtD
Mefenamic acid—Body temperature increased—Docetaxel—ovarian cancer	0.000222	0.000755	CcSEcCtD
Mefenamic acid—Arrhythmia—Doxorubicin—ovarian cancer	0.00022	0.000749	CcSEcCtD
Mefenamic acid—Dizziness—Paclitaxel—ovarian cancer	0.000219	0.000745	CcSEcCtD
Mefenamic acid—Vision blurred—Epirubicin—ovarian cancer	0.000219	0.000744	CcSEcCtD
Mefenamic acid—Alopecia—Doxorubicin—ovarian cancer	0.000218	0.000741	CcSEcCtD
Mefenamic acid—Mental disorder—Doxorubicin—ovarian cancer	0.000216	0.000735	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Epirubicin—ovarian cancer	0.000215	0.000732	CcSEcCtD
Mefenamic acid—Anaemia—Epirubicin—ovarian cancer	0.000214	0.000729	CcSEcCtD
Mefenamic acid—Flatulence—Doxorubicin—ovarian cancer	0.000211	0.000719	CcSEcCtD
Mefenamic acid—Tension—Doxorubicin—ovarian cancer	0.000211	0.000716	CcSEcCtD
Mefenamic acid—Vomiting—Paclitaxel—ovarian cancer	0.000211	0.000716	CcSEcCtD
Mefenamic acid—Malaise—Epirubicin—ovarian cancer	0.000209	0.000712	CcSEcCtD
Mefenamic acid—Rash—Paclitaxel—ovarian cancer	0.000209	0.00071	CcSEcCtD
Mefenamic acid—Dermatitis—Paclitaxel—ovarian cancer	0.000209	0.00071	CcSEcCtD
Mefenamic acid—Nervousness—Doxorubicin—ovarian cancer	0.000208	0.000709	CcSEcCtD
Mefenamic acid—Vertigo—Epirubicin—ovarian cancer	0.000208	0.000709	CcSEcCtD
Mefenamic acid—Syncope—Epirubicin—ovarian cancer	0.000208	0.000708	CcSEcCtD
Mefenamic acid—Leukopenia—Epirubicin—ovarian cancer	0.000208	0.000706	CcSEcCtD
Mefenamic acid—Headache—Paclitaxel—ovarian cancer	0.000207	0.000706	CcSEcCtD
Mefenamic acid—Palpitations—Epirubicin—ovarian cancer	0.000205	0.000697	CcSEcCtD
Mefenamic acid—Loss of consciousness—Epirubicin—ovarian cancer	0.000204	0.000694	CcSEcCtD
Mefenamic acid—Vision blurred—Doxorubicin—ovarian cancer	0.000202	0.000688	CcSEcCtD
Mefenamic acid—Asthenia—Docetaxel—ovarian cancer	0.000201	0.000685	CcSEcCtD
Mefenamic acid—Convulsion—Epirubicin—ovarian cancer	0.000201	0.000684	CcSEcCtD
Mefenamic acid—Hypertension—Epirubicin—ovarian cancer	0.0002	0.000681	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000199	0.000677	CcSEcCtD
Mefenamic acid—Pruritus—Docetaxel—ovarian cancer	0.000199	0.000676	CcSEcCtD
Mefenamic acid—Anaemia—Doxorubicin—ovarian cancer	0.000198	0.000675	CcSEcCtD
Mefenamic acid—Anxiety—Epirubicin—ovarian cancer	0.000197	0.000669	CcSEcCtD
Mefenamic acid—Nausea—Paclitaxel—ovarian cancer	0.000197	0.000669	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000196	0.000667	CcSEcCtD
Mefenamic acid—Discomfort—Epirubicin—ovarian cancer	0.000195	0.000664	CcSEcCtD
Mefenamic acid—Malaise—Doxorubicin—ovarian cancer	0.000194	0.000658	CcSEcCtD
Mefenamic acid—Dry mouth—Epirubicin—ovarian cancer	0.000193	0.000657	CcSEcCtD
Mefenamic acid—Vertigo—Doxorubicin—ovarian cancer	0.000193	0.000656	CcSEcCtD
Mefenamic acid—Syncope—Doxorubicin—ovarian cancer	0.000192	0.000655	CcSEcCtD
Mefenamic acid—Leukopenia—Doxorubicin—ovarian cancer	0.000192	0.000654	CcSEcCtD
Mefenamic acid—Diarrhoea—Docetaxel—ovarian cancer	0.000192	0.000653	CcSEcCtD
Mefenamic acid—Confusional state—Epirubicin—ovarian cancer	0.000191	0.000649	CcSEcCtD
Mefenamic acid—Palpitations—Doxorubicin—ovarian cancer	0.00019	0.000645	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Epirubicin—ovarian cancer	0.000189	0.000644	CcSEcCtD
Mefenamic acid—Oedema—Epirubicin—ovarian cancer	0.000189	0.000644	CcSEcCtD
Mefenamic acid—Loss of consciousness—Doxorubicin—ovarian cancer	0.000189	0.000642	CcSEcCtD
Mefenamic acid—Infection—Epirubicin—ovarian cancer	0.000188	0.00064	CcSEcCtD
Mefenamic acid—Shock—Epirubicin—ovarian cancer	0.000186	0.000634	CcSEcCtD
Mefenamic acid—Convulsion—Doxorubicin—ovarian cancer	0.000186	0.000633	CcSEcCtD
Mefenamic acid—Dizziness—Docetaxel—ovarian cancer	0.000186	0.000631	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Epirubicin—ovarian cancer	0.000185	0.000631	CcSEcCtD
Mefenamic acid—Hypertension—Doxorubicin—ovarian cancer	0.000185	0.00063	CcSEcCtD
Mefenamic acid—Tachycardia—Epirubicin—ovarian cancer	0.000185	0.000629	CcSEcCtD
Mefenamic acid—Skin disorder—Epirubicin—ovarian cancer	0.000184	0.000626	CcSEcCtD
Mefenamic acid—Anxiety—Doxorubicin—ovarian cancer	0.000182	0.000619	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000181	0.000617	CcSEcCtD
Mefenamic acid—Discomfort—Doxorubicin—ovarian cancer	0.000181	0.000614	CcSEcCtD
Mefenamic acid—Anorexia—Epirubicin—ovarian cancer	0.00018	0.000614	CcSEcCtD
Mefenamic acid—Dry mouth—Doxorubicin—ovarian cancer	0.000179	0.000608	CcSEcCtD
Mefenamic acid—Vomiting—Docetaxel—ovarian cancer	0.000178	0.000607	CcSEcCtD
Mefenamic acid—Rash—Docetaxel—ovarian cancer	0.000177	0.000602	CcSEcCtD
Mefenamic acid—Hypotension—Epirubicin—ovarian cancer	0.000177	0.000602	CcSEcCtD
Mefenamic acid—Dermatitis—Docetaxel—ovarian cancer	0.000177	0.000601	CcSEcCtD
Mefenamic acid—Confusional state—Doxorubicin—ovarian cancer	0.000177	0.000601	CcSEcCtD
Mefenamic acid—Headache—Docetaxel—ovarian cancer	0.000176	0.000598	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000175	0.000596	CcSEcCtD
Mefenamic acid—Oedema—Doxorubicin—ovarian cancer	0.000175	0.000596	CcSEcCtD
Mefenamic acid—Infection—Doxorubicin—ovarian cancer	0.000174	0.000592	CcSEcCtD
Mefenamic acid—Shock—Doxorubicin—ovarian cancer	0.000172	0.000586	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000171	0.000583	CcSEcCtD
Mefenamic acid—Insomnia—Epirubicin—ovarian cancer	0.000171	0.000582	CcSEcCtD
Mefenamic acid—Tachycardia—Doxorubicin—ovarian cancer	0.000171	0.000582	CcSEcCtD
Mefenamic acid—Skin disorder—Doxorubicin—ovarian cancer	0.00017	0.000579	CcSEcCtD
Mefenamic acid—Paraesthesia—Epirubicin—ovarian cancer	0.00017	0.000578	CcSEcCtD
Mefenamic acid—Dyspnoea—Epirubicin—ovarian cancer	0.000169	0.000574	CcSEcCtD
Mefenamic acid—Somnolence—Epirubicin—ovarian cancer	0.000168	0.000573	CcSEcCtD
Mefenamic acid—Anorexia—Doxorubicin—ovarian cancer	0.000167	0.000568	CcSEcCtD
Mefenamic acid—Nausea—Docetaxel—ovarian cancer	0.000167	0.000567	CcSEcCtD
Mefenamic acid—Dyspepsia—Epirubicin—ovarian cancer	0.000167	0.000567	CcSEcCtD
Mefenamic acid—Decreased appetite—Epirubicin—ovarian cancer	0.000165	0.00056	CcSEcCtD
Mefenamic acid—Hypotension—Doxorubicin—ovarian cancer	0.000164	0.000557	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000163	0.000556	CcSEcCtD
Mefenamic acid—Constipation—Epirubicin—ovarian cancer	0.000162	0.000551	CcSEcCtD
Mefenamic acid—Insomnia—Doxorubicin—ovarian cancer	0.000158	0.000539	CcSEcCtD
Mefenamic acid—Paraesthesia—Doxorubicin—ovarian cancer	0.000157	0.000535	CcSEcCtD
Mefenamic acid—Dyspnoea—Doxorubicin—ovarian cancer	0.000156	0.000531	CcSEcCtD
Mefenamic acid—Feeling abnormal—Epirubicin—ovarian cancer	0.000156	0.000531	CcSEcCtD
Mefenamic acid—Somnolence—Doxorubicin—ovarian cancer	0.000156	0.00053	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000155	0.000527	CcSEcCtD
Mefenamic acid—Dyspepsia—Doxorubicin—ovarian cancer	0.000154	0.000525	CcSEcCtD
Mefenamic acid—Decreased appetite—Doxorubicin—ovarian cancer	0.000152	0.000518	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000151	0.000514	CcSEcCtD
Mefenamic acid—Urticaria—Epirubicin—ovarian cancer	0.00015	0.000512	CcSEcCtD
Mefenamic acid—Constipation—Doxorubicin—ovarian cancer	0.00015	0.00051	CcSEcCtD
Mefenamic acid—Abdominal pain—Epirubicin—ovarian cancer	0.00015	0.000509	CcSEcCtD
Mefenamic acid—Body temperature increased—Epirubicin—ovarian cancer	0.00015	0.000509	CcSEcCtD
Mefenamic acid—Feeling abnormal—Doxorubicin—ovarian cancer	0.000144	0.000491	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000143	0.000487	CcSEcCtD
Mefenamic acid—Urticaria—Doxorubicin—ovarian cancer	0.000139	0.000473	CcSEcCtD
Mefenamic acid—Abdominal pain—Doxorubicin—ovarian cancer	0.000138	0.000471	CcSEcCtD
Mefenamic acid—Body temperature increased—Doxorubicin—ovarian cancer	0.000138	0.000471	CcSEcCtD
Mefenamic acid—Asthenia—Epirubicin—ovarian cancer	0.000136	0.000462	CcSEcCtD
Mefenamic acid—Pruritus—Epirubicin—ovarian cancer	0.000134	0.000456	CcSEcCtD
Mefenamic acid—Diarrhoea—Epirubicin—ovarian cancer	0.00013	0.000441	CcSEcCtD
Mefenamic acid—Asthenia—Doxorubicin—ovarian cancer	0.000126	0.000428	CcSEcCtD
Mefenamic acid—Dizziness—Epirubicin—ovarian cancer	0.000125	0.000426	CcSEcCtD
Mefenamic acid—Pruritus—Doxorubicin—ovarian cancer	0.000124	0.000422	CcSEcCtD
Mefenamic acid—Vomiting—Epirubicin—ovarian cancer	0.00012	0.000409	CcSEcCtD
Mefenamic acid—Diarrhoea—Doxorubicin—ovarian cancer	0.00012	0.000408	CcSEcCtD
Mefenamic acid—Rash—Epirubicin—ovarian cancer	0.000119	0.000406	CcSEcCtD
Mefenamic acid—Dermatitis—Epirubicin—ovarian cancer	0.000119	0.000406	CcSEcCtD
Mefenamic acid—Headache—Epirubicin—ovarian cancer	0.000119	0.000403	CcSEcCtD
Mefenamic acid—Dizziness—Doxorubicin—ovarian cancer	0.000116	0.000394	CcSEcCtD
Mefenamic acid—Nausea—Epirubicin—ovarian cancer	0.000112	0.000383	CcSEcCtD
Mefenamic acid—Vomiting—Doxorubicin—ovarian cancer	0.000111	0.000379	CcSEcCtD
Mefenamic acid—Rash—Doxorubicin—ovarian cancer	0.00011	0.000376	CcSEcCtD
Mefenamic acid—Dermatitis—Doxorubicin—ovarian cancer	0.00011	0.000375	CcSEcCtD
Mefenamic acid—Headache—Doxorubicin—ovarian cancer	0.00011	0.000373	CcSEcCtD
Mefenamic acid—Nausea—Doxorubicin—ovarian cancer	0.000104	0.000354	CcSEcCtD
Mefenamic acid—AKR1C1—Metabolism—PIK3CD—ovarian cancer	6.05e-05	0.000645	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—IL6ST—ovarian cancer	5.99e-05	0.000639	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—CDKN1B—ovarian cancer	5.91e-05	0.00063	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	5.9e-05	0.00063	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	5.84e-05	0.000624	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PPP2R1A—ovarian cancer	5.78e-05	0.000617	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—IL6ST—ovarian cancer	5.75e-05	0.000614	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PIK3CG—ovarian cancer	5.75e-05	0.000614	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—APC—ovarian cancer	5.75e-05	0.000614	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—TP53—ovarian cancer	5.71e-05	0.00061	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	5.69e-05	0.000608	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—CTNNB1—ovarian cancer	5.58e-05	0.000595	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—APC—ovarian cancer	5.53e-05	0.00059	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—PTEN—ovarian cancer	5.44e-05	0.00058	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PPP1CC—ovarian cancer	5.41e-05	0.000577	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—BRIP1—ovarian cancer	5.41e-05	0.000577	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	5.4e-05	0.000577	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	5.4e-05	0.000576	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—PIK3CB—ovarian cancer	5.27e-05	0.000562	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—IL6—ovarian cancer	5.23e-05	0.000558	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	5.14e-05	0.000549	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—CAV1—ovarian cancer	5.08e-05	0.000542	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PIK3CD—ovarian cancer	5.06e-05	0.00054	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CYTB—ovarian cancer	5.04e-05	0.000537	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	4.97e-05	0.00053	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	4.92e-05	0.000525	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—HDAC6—ovarian cancer	4.9e-05	0.000522	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	4.87e-05	0.000519	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—STAT3—ovarian cancer	4.86e-05	0.000519	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PIK3CD—ovarian cancer	4.86e-05	0.000519	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.85e-05	0.000518	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—NRAS—ovarian cancer	4.85e-05	0.000518	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	4.73e-05	0.000505	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—MAPK3—ovarian cancer	4.65e-05	0.000496	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	4.63e-05	0.000494	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	4.63e-05	0.000494	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PIK3CG—ovarian cancer	4.63e-05	0.000494	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TERT—ovarian cancer	4.59e-05	0.00049	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—YAP1—ovarian cancer	4.57e-05	0.000488	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—PTEN—ovarian cancer	4.55e-05	0.000486	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	4.52e-05	0.000483	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—MYC—ovarian cancer	4.52e-05	0.000482	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—ERBB2—ovarian cancer	4.47e-05	0.000477	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—MAPK1—ovarian cancer	4.42e-05	0.000472	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—EGFR—ovarian cancer	4.42e-05	0.000472	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PIK3CB—ovarian cancer	4.41e-05	0.00047	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MTOR—ovarian cancer	4.41e-05	0.00047	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—BRIP1—ovarian cancer	4.4e-05	0.00047	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PPP1CC—ovarian cancer	4.4e-05	0.00047	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	4.4e-05	0.000469	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—PIK3CA—ovarian cancer	4.38e-05	0.000467	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	4.37e-05	0.000467	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—ERBB2—ovarian cancer	4.29e-05	0.000458	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CAV1—ovarian cancer	4.25e-05	0.000453	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—XIAP—ovarian cancer	4.25e-05	0.000453	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CXCL8—ovarian cancer	4.24e-05	0.000452	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PIK3CB—ovarian cancer	4.23e-05	0.000452	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—MTOR—ovarian cancer	4.23e-05	0.000452	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—KRAS—ovarian cancer	4.18e-05	0.000446	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—SMARCA4—ovarian cancer	4.14e-05	0.000441	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CDKN1B—ovarian cancer	4.14e-05	0.000441	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CYTB—ovarian cancer	4.1e-05	0.000437	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—ESR1—ovarian cancer	4.09e-05	0.000437	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PIK3CD—ovarian cancer	4.07e-05	0.000434	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CASP3—ovarian cancer	4.05e-05	0.000433	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—IL2—ovarian cancer	4.05e-05	0.000432	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—EREG—ovarian cancer	4.04e-05	0.000431	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IL6ST—ovarian cancer	4.03e-05	0.00043	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	4.02e-05	0.000429	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	4.01e-05	0.000428	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.98e-05	0.000424	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CDKN1B—ovarian cancer	3.97e-05	0.000424	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CCND1—ovarian cancer	3.95e-05	0.000421	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.94e-05	0.000421	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CTNNB1—ovarian cancer	3.91e-05	0.000417	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	3.89e-05	0.000415	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—APC—ovarian cancer	3.87e-05	0.000413	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PIK3CG—ovarian cancer	3.87e-05	0.000413	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—PIK3CA—ovarian cancer	3.84e-05	0.000409	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MMP9—ovarian cancer	3.83e-05	0.000409	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PTEN—ovarian cancer	3.81e-05	0.000406	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CTNNB1—ovarian cancer	3.75e-05	0.000401	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—FASN—ovarian cancer	3.73e-05	0.000398	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—SLC5A5—ovarian cancer	3.67e-05	0.000391	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PTEN—ovarian cancer	3.66e-05	0.000391	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—YAP1—ovarian cancer	3.63e-05	0.000387	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.59e-05	0.000383	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PPP1CC—ovarian cancer	3.58e-05	0.000382	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—BRIP1—ovarian cancer	3.58e-05	0.000382	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—AKT1—ovarian cancer	3.58e-05	0.000382	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—HRAS—ovarian cancer	3.55e-05	0.000379	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PIK3CB—ovarian cancer	3.55e-05	0.000378	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—SLC2A1—ovarian cancer	3.54e-05	0.000378	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—FASN—ovarian cancer	3.53e-05	0.000377	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PARP1—ovarian cancer	3.52e-05	0.000375	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.47e-05	0.00037	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—VEGFA—ovarian cancer	3.44e-05	0.000367	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—STAT3—ovarian cancer	3.41e-05	0.000363	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PIK3CD—ovarian cancer	3.4e-05	0.000363	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—NRAS—ovarian cancer	3.4e-05	0.000363	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—IL6—ovarian cancer	3.4e-05	0.000363	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CYP1B1—ovarian cancer	3.39e-05	0.000362	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—SLC2A1—ovarian cancer	3.36e-05	0.000358	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	3.28e-05	0.00035	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—STAT3—ovarian cancer	3.27e-05	0.000349	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—NRAS—ovarian cancer	3.26e-05	0.000348	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MAPK3—ovarian cancer	3.25e-05	0.000347	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—PIK3CA—ovarian cancer	3.21e-05	0.000343	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.21e-05	0.000342	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MYC—ovarian cancer	3.16e-05	0.000338	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.16e-05	0.000337	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—AKT1—ovarian cancer	3.13e-05	0.000334	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—MAPK3—ovarian cancer	3.13e-05	0.000334	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MAPK1—ovarian cancer	3.1e-05	0.00033	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—EGFR—ovarian cancer	3.1e-05	0.00033	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PTEN—ovarian cancer	3.06e-05	0.000327	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—MYC—ovarian cancer	3.04e-05	0.000325	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PPP2R1A—ovarian cancer	3.01e-05	0.000321	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—ERBB2—ovarian cancer	3.01e-05	0.000321	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3e-05	0.00032	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—MAPK1—ovarian cancer	2.98e-05	0.000317	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—EGFR—ovarian cancer	2.97e-05	0.000317	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PIK3CB—ovarian cancer	2.97e-05	0.000316	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MTOR—ovarian cancer	2.97e-05	0.000316	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—FASN—ovarian cancer	2.96e-05	0.000316	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—YAP1—ovarian cancer	2.95e-05	0.000315	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—KRAS—ovarian cancer	2.92e-05	0.000312	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.92e-05	0.000312	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—SLC5A5—ovarian cancer	2.91e-05	0.000311	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PPP2R1A—ovarian cancer	2.85e-05	0.000304	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CXCL8—ovarian cancer	2.85e-05	0.000304	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—SLC2A1—ovarian cancer	2.81e-05	0.0003	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—KRAS—ovarian cancer	2.81e-05	0.0003	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ABCB1—ovarian cancer	2.79e-05	0.000298	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CDKN1B—ovarian cancer	2.78e-05	0.000297	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.75e-05	0.000294	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—TYMS—ovarian cancer	2.74e-05	0.000293	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CASP3—ovarian cancer	2.73e-05	0.000291	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IL2—ovarian cancer	2.72e-05	0.000291	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CYP1B1—ovarian cancer	2.69e-05	0.000288	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PIK3CA—ovarian cancer	2.69e-05	0.000287	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CCND1—ovarian cancer	2.66e-05	0.000283	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CTNNB1—ovarian cancer	2.63e-05	0.000281	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—AKT1—ovarian cancer	2.62e-05	0.00028	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.61e-05	0.000279	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—TP53—ovarian cancer	2.6e-05	0.000277	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PIK3CA—ovarian cancer	2.58e-05	0.000276	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MMP9—ovarian cancer	2.58e-05	0.000275	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.57e-05	0.000274	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PTEN—ovarian cancer	2.56e-05	0.000273	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—HRAS—ovarian cancer	2.49e-05	0.000265	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—FASN—ovarian cancer	2.41e-05	0.000257	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—YAP1—ovarian cancer	2.4e-05	0.000256	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PPP2R1A—ovarian cancer	2.39e-05	0.000255	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—HRAS—ovarian cancer	2.39e-05	0.000255	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—IL6—ovarian cancer	2.38e-05	0.000254	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.38e-05	0.000254	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.38e-05	0.000254	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—SLC5A5—ovarian cancer	2.37e-05	0.000253	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—VEGFA—ovarian cancer	2.31e-05	0.000247	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—STAT3—ovarian cancer	2.29e-05	0.000245	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—SLC2A1—ovarian cancer	2.29e-05	0.000244	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—NRAS—ovarian cancer	2.29e-05	0.000244	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—IL6—ovarian cancer	2.29e-05	0.000244	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—TERT—ovarian cancer	2.27e-05	0.000242	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.24e-05	0.000239	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ABCB1—ovarian cancer	2.22e-05	0.000237	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CAV1—ovarian cancer	2.21e-05	0.000236	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—AKT1—ovarian cancer	2.19e-05	0.000234	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CYP1B1—ovarian cancer	2.19e-05	0.000234	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MAPK3—ovarian cancer	2.19e-05	0.000234	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—TYMS—ovarian cancer	2.18e-05	0.000233	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PIK3CA—ovarian cancer	2.16e-05	0.000231	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MYC—ovarian cancer	2.13e-05	0.000227	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.11e-05	0.000226	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—AKT1—ovarian cancer	2.11e-05	0.000225	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CAV1—ovarian cancer	2.1e-05	0.000224	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.09e-05	0.000223	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MAPK1—ovarian cancer	2.08e-05	0.000222	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—EGFR—ovarian cancer	2.08e-05	0.000222	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PIK3CG—ovarian cancer	2.01e-05	0.000215	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—IL6ST—ovarian cancer	1.99e-05	0.000212	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—KRAS—ovarian cancer	1.97e-05	0.00021	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—FASN—ovarian cancer	1.96e-05	0.000209	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	1.94e-05	0.000207	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.93e-05	0.000206	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—SLC5A5—ovarian cancer	1.93e-05	0.000206	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—APC—ovarian cancer	1.91e-05	0.000204	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—SLC2A1—ovarian cancer	1.86e-05	0.000199	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.82e-05	0.000194	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PIK3CA—ovarian cancer	1.81e-05	0.000193	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ABCB1—ovarian cancer	1.81e-05	0.000193	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CYP1B1—ovarian cancer	1.78e-05	0.00019	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—TYMS—ovarian cancer	1.77e-05	0.000189	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PIK3CD—ovarian cancer	1.77e-05	0.000189	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—AKT1—ovarian cancer	1.77e-05	0.000188	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CAV1—ovarian cancer	1.76e-05	0.000187	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TP53—ovarian cancer	1.75e-05	0.000187	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PIK3CD—ovarian cancer	1.68e-05	0.000179	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.68e-05	0.000179	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—HRAS—ovarian cancer	1.67e-05	0.000178	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IL6—ovarian cancer	1.6e-05	0.000171	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PIK3CG—ovarian cancer	1.6e-05	0.000171	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	1.58e-05	0.000169	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.57e-05	0.000168	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PIK3CB—ovarian cancer	1.54e-05	0.000165	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—ERBB2—ovarian cancer	1.48e-05	0.000158	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—AKT1—ovarian cancer	1.48e-05	0.000158	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ABCB1—ovarian cancer	1.47e-05	0.000157	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PIK3CB—ovarian cancer	1.46e-05	0.000156	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—MTOR—ovarian cancer	1.46e-05	0.000156	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—TYMS—ovarian cancer	1.44e-05	0.000154	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CAV1—ovarian cancer	1.43e-05	0.000152	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PIK3CD—ovarian cancer	1.41e-05	0.00015	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CDKN1B—ovarian cancer	1.37e-05	0.000147	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.36e-05	0.000146	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PTEN—ovarian cancer	1.33e-05	0.000142	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PIK3CG—ovarian cancer	1.3e-05	0.000139	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CTNNB1—ovarian cancer	1.3e-05	0.000138	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PTEN—ovarian cancer	1.26e-05	0.000135	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PIK3CB—ovarian cancer	1.23e-05	0.000131	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CAV1—ovarian cancer	1.16e-05	0.000124	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PIK3CD—ovarian cancer	1.14e-05	0.000122	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—STAT3—ovarian cancer	1.13e-05	0.000121	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NRAS—ovarian cancer	1.13e-05	0.00012	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.11e-05	0.000119	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—MAPK3—ovarian cancer	1.08e-05	0.000115	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PIK3CG—ovarian cancer	1.06e-05	0.000113	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PTEN—ovarian cancer	1.06e-05	0.000113	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—MYC—ovarian cancer	1.05e-05	0.000112	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—MAPK1—ovarian cancer	1.03e-05	0.00011	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—EGFR—ovarian cancer	1.03e-05	0.00011	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PIK3CB—ovarian cancer	9.97e-06	0.000106	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—KRAS—ovarian cancer	9.71e-06	0.000104	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PIK3CA—ovarian cancer	9.41e-06	0.0001	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PIK3CD—ovarian cancer	9.31e-06	9.94e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PIK3CA—ovarian cancer	8.92e-06	9.52e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PTEN—ovarian cancer	8.62e-06	9.2e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—HRAS—ovarian cancer	8.25e-06	8.81e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PIK3CB—ovarian cancer	8.12e-06	8.66e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—IL6—ovarian cancer	7.9e-06	8.43e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—AKT1—ovarian cancer	7.69e-06	8.2e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PIK3CA—ovarian cancer	7.47e-06	7.97e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—AKT1—ovarian cancer	7.29e-06	7.78e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PTEN—ovarian cancer	7.01e-06	7.48e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—AKT1—ovarian cancer	6.1e-06	6.51e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PIK3CA—ovarian cancer	6.08e-06	6.49e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—AKT1—ovarian cancer	4.97e-06	5.3e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PIK3CA—ovarian cancer	4.95e-06	5.28e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—AKT1—ovarian cancer	4.04e-06	4.31e-05	CbGpPWpGaD
